TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 168 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $14,746,000 | +373.8% | 195,959 | +69.1% | 0.17% | +507.1% |
| Q1 2022 | $3,112,000 | -81.6% | 115,897 | -67.3% | 0.03% | -78.9% |
| Q4 2021 | $16,886,000 | +18.4% | 354,007 | +64.8% | 0.13% | +18.8% |
| Q3 2021 | $14,266,000 | -32.7% | 214,758 | -21.0% | 0.11% | -27.7% |
| Q2 2021 | $21,208,000 | +5959.4% | 271,834 | +7248.9% | 0.16% | +5066.7% |
| Q1 2021 | $350,000 | -97.8% | 3,699 | -97.2% | 0.00% | -97.5% |
| Q4 2020 | $16,137,000 | +42.7% | 132,432 | +2.3% | 0.12% | +20.2% |
| Q3 2020 | $11,310,000 | – | 129,468 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |